{"entity":{"id":"nct02887040","kind":"trial","name":"Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma","aka":[],"tldr":"A phase 3 trial of Antineoplastons in Glioma & glioblastoma, run by Burzynski Research Institute, not yet recruiting.","summary":"Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma is a phase 3 interventional study registered as NCT02887040 by Burzynski Research Institute, with 92 participants planned, started 2025-10-01 and due to reach its primary completion in 2026-06. Interventions recorded: Radiation, Atengenal, Astugenal. Conditions recorded: Brain Stem Glioma.\n\nLinked to the technology Antineoplastons because the registry's title names it (\"antineoplastons\") and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.","status":"planned","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT02887040","url":"https://clinicaltrials.gov/study/NCT02887040"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["glioblastoma"],"sections":[],"technologies":["antineoplastons"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02887040","phase":"3","setting":"A Randomized Phase 3 Study of Combination Antineoplaston Therapy [Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal)] Plus Radiation Therapy vs. Radiation Therapy Only in Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem Glioma","sponsor":"Burzynski Research Institute","enrolled":92,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02887040/","neighbours":{"cancer":[{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"}],"technology":[{"id":"antineoplastons","kind":"technology","name":"Antineoplastons (Burzynski clinic)","route":"/technologies/antineoplastons/"}]}}